FibroGen
FGEN
FGEN
213 hedge funds and large institutions have $2.63B invested in FibroGen in 2019 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 82 increasing their positions, 64 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.02% more ownership
Funds ownership: 2.8% → 2.82% (+0.02%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less call options, than puts
Call options by funds: $37.3M | Put options by funds: $38.5M
Holders
213
Holding in Top 10
2
Calls
$37.3M
Puts
$38.5M
Top Buyers
| 1 | +$44.8M | |
| 2 | +$30.3M | |
| 3 | +$19.4M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$15M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$10.2M |
Top Sellers
| 1 | -$55.5M | |
| 2 | -$11.7M | |
| 3 | -$11.4M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$11M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$9.74M |